|1.||Moghaddam, Seyed Javad: 2 articles (04/2014 - 04/2009)|
|2.||Wille, K: 2 articles (02/2014 - 03/2011)|
|3.||Palmer, S M: 2 articles (02/2014 - 03/2011)|
|4.||Weinacker, A: 2 articles (02/2014 - 03/2011)|
|5.||Demissie, E: 2 articles (02/2014 - 03/2011)|
|6.||Diamond, J M: 2 articles (02/2014 - 03/2011)|
|7.||Kawut, S M: 2 articles (02/2014 - 03/2011)|
|8.||Lederer, D J: 2 articles (02/2014 - 03/2011)|
|9.||Bhorade, S: 2 articles (02/2014 - 03/2011)|
|10.||Christie, J D: 2 articles (02/2014 - 03/2011)|
|1.||Respiratory Insufficiency (Respiratory Failure)
|2.||Asthma (Bronchial Asthma)
07/01/2002 - "An association study between the Clara cell secretory protein CC16 A38G polymorphism and asthma phenotypes."
07/01/2013 - "Serum levels of Clara cell secretory protein, asthma, and lung function in the adult general population."
06/01/2011 - "We hypothesize that children with AR who have the Clara cell secretory protein (CC16, secretoglobin 1A1) 38A/38A genotype (rs3741240) have an increased likelihood of developing asthma. "
03/01/2004 - "Clara cell secretory protein: determination of serum levels by an enzyme immunoassay and its importance as an indicator of bronchial asthma in children."
07/01/2003 - "[Expression of Clara cell secretory protein in airways of rat asthma remodel]."
11/01/2008 - "The aim of this study was to assess the serum concentrations of Clara cell secretory protein (CC16) in association with acute and chronic lung injury in mechanically ventilated preterm neonates. "
11/01/2008 - "Clara cell secretory protein (CC16) as a peripheral blood biomarker of lung injury in ventilated preterm neonates."
03/01/2008 - "To investigate the kinetics and the determinants of the changes of the Clara cell 16 kDa protein (CC16) as a marker of lung injury following exposure to different toxicants. "
04/01/2005 - "To determine the roles of mechanically activated cytosolic PLA2 (cPLA2)and Clara cell secretory protein (CCSP), a modulator of cPLA2 activity, we compared lung injury with and without a PLA2 inhibitor in wild-type mice and CCSP-null mice (CCSP-/-) ventilated with high and low peak inflation pressures (PIP) for 2- or 4-h periods. "
06/01/1996 - "p172: An alveolar type II and Clara cell specific protein with late developmental expression and upregulation by hyperoxic lung injury."
11/01/2013 - "Clara cell secretory protein (CC16) is expressed primarily in the respiratory tract and is a potent anti-inflammatory agent that protects the airway from inflammation. "
01/01/2011 - "Clara cell secretory protein (CCSP) is much reduced during active inflammation when neutrophils predominate in the airways, and in chronic asthmatics. "
01/01/2010 - "Clara cell secretory protein in tracheobronchial aspirates and umbilical cord serum of extremely premature infants with systemic inflammation."
07/01/2009 - "Clara cell secretory protein (CCSP) counters inflammation in the lung, hence we hypothesized that CCSP depletion is a key feature of RAO in horses. "
01/01/2003 - "One protein induced by IFN-gamma is Clara cell secretory protein (CCSP), which may contribute to the attenuation of airway inflammation. "
08/01/1997 - "Altered pulmonary response to hyperoxia in Clara cell secretory protein deficient mice."
05/01/2007 - "[Effects of recombinant human insulin-like growth factor-1 on the expression of Clara cell secretory protein in lung of hyperoxia-exposed newborn rats]."
04/01/2005 - "During hyperoxia, Gadd45a deficiency did not affect loss of airway epithelial expression of Clara cell secretory protein or type II epithelial cell expression of pro-surfactant protein C. "
11/01/1999 - "Clara cell secretory protein (CCSP) deficiency in mice is associated with increased susceptibility to pulmonary inflammation after hyperoxia or viral infection. "
05/01/2007 - "The purpose of this study was to investigate the influence of recombinant human insulin-like growth factor-1 (rh-IGF-1) on cell apoptosis and Clara cell secretory protein (CCSP) expression during the lung injury induced by hyperoxia, so as to assess its effect on the inflammatory lung injury and its developmental repair. "
|1.||Proteins (Proteins, Gene)
|4.||Immunoglobulin E (IgE)
|6.||Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)
|7.||Messenger RNA (mRNA)
|8.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|9.||Phospholipases A2 (Phospholipase A2)
|10.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|2.||Stem Cell Transplantation
|3.||Transplantation (Transplant Recipients)
|4.||Mechanical Ventilators (Ventilator)